Net Income for Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's current net income (TTM) is $6.28B USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet IncomeSwitch metric
TTM (last 4 quarters)
$6.28B
YoY change
-51.3%
5Y CAGR
+7.7%
Peak year (2024)
$13.40B
Cumulative net income
$129.01B
Net Income history chart for Abbott Laboratories (ABT) from 1985 to 2025
Net Income history table for Abbott Laboratories (ABT) from 1985 to 2025
| Fiscal year | Period ended | Reported | Net Income | YoY |
|---|---|---|---|---|
| 2025 | $6.52B | -51.3% | ||
| 2024 | $13.40B | +134.2% | ||
| 2023 | $5.72B | -17.5% | ||
| 2022 | $6.93B | -2.0% | ||
| 2021 | $7.07B | +57.3% | ||
| 2020 | $4.50B | +21.9% | ||
| 2019 | $3.69B | +55.7% | ||
| 2018 | $2.37B | +396.4% | ||
| 2017 | $477.00M | -65.9% | ||
| 2016 | $1.40B | -68.3% | ||
| 2015 | $4.42B | +93.7% | ||
| 2014 | $2.28B | -11.3% | ||
| 2013 | $2.58B | -56.8% | ||
| 2012 | $5.96B | +26.1% | ||
| 2011 | $4.73B | +2.2% | ||
| 2010 | $4.63B | -19.5% | ||
| 2009 | $5.75B | +17.7% | ||
| 2008 | $4.88B | +35.3% | ||
| 2007 | $3.61B | +110.1% | ||
| 2006 | $1.72B | -49.1% | ||
| 2005 | $3.37B | +4.2% | ||
| 2004 | $3.24B | +17.5% | ||
| 2003 | $2.75B | -1.4% | ||
| 2002 | $2.79B | +80.2% | ||
| 2001 | $1.55B | -44.4% | ||
| 2000 | $2.79B | +13.9% | ||
| 1999 | $2.45B | +4.8% | ||
| 1998 | $2.33B | +12.3% | ||
| 1997 | $2.08B | +10.5% | ||
| 1996 | $1.88B | +11.4% | ||
| 1995 | $1.69B | +11.3% | ||
| 1994 | $1.52B | +8.4% | ||
| 1993 | $1.40B | +12.9% | ||
| 1992 | $1.24B | +13.8% | ||
| 1991 | $1.09B | +12.7% | ||
| 1990 | $965.80M | +12.3% | ||
| 1989 | $859.80M | +14.3% | ||
| 1988 | $752.00M | +18.9% | ||
| 1987 | $632.60M | +17.0% | ||
| 1986 | $540.50M | +16.2% | ||
| 1985 | $465.30M | — |
Net Income values are taken from Abbott Laboratories's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual net income for Abbott Laboratories (ABT) came in at $6.52B – plunged 51.3% year-over-year.
Through 2020–2025 (5 years), Abbott Laboratories net income delivered a +7.7% annualised rate; with the latest reading among the more recent periods of the dataset.
Abbott Laboratories net income peaked at $13.40B in 2024; the latest annual figure is $6.52B in 2025 (51.3% below peak).
The highest annual net income of $13.40B was reported in 2024. The lowest in the available history was $465.30M in 1985.
Within Healthcare, Abbott Laboratories (ABT) ranks 8th among 8 peers we track. The peer median for net income is $15.15B.
Abbott Laboratories Net Income by Year
Abbott Laboratories Net Income 2025: $6.52B
Abbott Laboratories net income in 2025 was $6.52B, plunged 51.3% below 2024.
Abbott Laboratories Net Income 2024: $13.40B
Abbott Laboratories net income in 2024 was $13.40B, surged 134.2% from 2023. This figure represents the highest annual value in the available history.
Abbott Laboratories Net Income 2023: $5.72B
Abbott Laboratories net income in 2023 was $5.72B, declined 17.5% below 2022.
Abbott Laboratories Net Income 2022: $6.93B
Abbott Laboratories net income in 2022 was $6.93B, edged down 2.0% below 2021.
Abbott Laboratories Net Income 2021: $7.07B
Abbott Laboratories net income in 2021 was $7.07B.
See more financial history for Abbott Laboratories (ABT).
Sector peers — Net Income
Companies in the same sector as Abbott Laboratories, ranked by their latest net income.
| Company | Net Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $102.43B | Healthcare |
| Johnson & Johnson (JNJ) | $26.80B | Healthcare |
| Eli Lilly and Company (LLY) | $20.64B | Healthcare |
| Merck & Co., Inc. (MRK) | $18.25B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $12.06B | Healthcare |
| AstraZeneca PLC (AZN) | $10.26B | Healthcare |
| Amgen Inc. (AMGN) | $7.71B | Healthcare |
| AbbVie Inc. (ABBV) | $4.23B | Healthcare |
Frequently asked questions
What is Abbott Laboratories's net income?
- Latest reported net income for Abbott Laboratories (ABT) is $6.28B (period ending March 31, 2026).
How has Abbott Laboratories net income changed year-over-year?
- Abbott Laboratories (ABT) net income changed -51.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories net income?
- Abbott Laboratories (ABT) net income compound annual growth rate is +7.7% over the most recent 5 years available.
When did Abbott Laboratories net income hit its highest annual value?
- Abbott Laboratories net income reached its highest annual value of $13.40B in 2024.
What was Abbott Laboratories net income in 2024?
- Abbott Laboratories (ABT) net income in 2024 was $13.40B.
What was Abbott Laboratories net income in 2025?
- Abbott Laboratories (ABT) net income in 2025 was $6.52B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.